tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Zealand Pharma (ZLDPF)
OTHER OTC:ZLDPF
US Market
ZLDPF
Zealand Pharma
RESEARCH TOOLSreports

Zealand Pharma (ZLDPF) Stock News & Sentiment

Compare
189 Followers
Zealand Pharma’s Earnings Call: Strong Growth Amid Challenges
Premium
Company Announcements
Zealand Pharma’s Earnings Call: Strong Growth Amid Challenges
1M ago
Zealand Pharma Reports Strong 2025 Performance
Premium
Company Announcements
Zealand Pharma Reports Strong 2025 Performance
1M ago
Zealand Pharma A/S (ZLDPF) Q3 Earnings Cheat Sheet
Premium
Pre-Earnings
Zealand Pharma A/S (ZLDPF) Q3 Earnings Cheat Sheet
1M ago
Zealand Pharma’s Phase 3 Trial of Glepaglutide: A Potential Breakthrough for SBS Treatment
Premium
Company Announcements
Zealand Pharma’s Phase 3 Trial of Glepaglutide: A Potential Breakthrough for SBS Treatment
2M ago
ZLDPF
Zealand Pharma’s Petrelintide Study: A Potential Game-Changer for Diabetes Management
Premium
Company Announcements
Zealand Pharma’s Petrelintide Study: A Potential Game-Changer for Diabetes Management
2M ago
ZLDPF
Zealand Pharma’s ZP9830 Study: A Potential Game-Changer in Autoimmune Treatment
Premium
Company Announcements
Zealand Pharma’s ZP9830 Study: A Potential Game-Changer in Autoimmune Treatment
2M ago
ZLDPF
M&A News: 89bio Stock (ETNB) Jumps 83% on $3.5B Acquisition by Roche
Premium
Market News
M&A News: 89bio Stock (ETNB) Jumps 83% on $3.5B Acquisition by Roche
3M ago
ETNB
More ZLDPF News >

ZLDPF News on the Web

Danish weight loss drug maker outlines ambitious 2030 strategy, ramping up pressure on Novo, Lilly
CNBC
Neutral
Alvotech (ALVO) Reports Q3 Loss, Misses Revenue Estimates
Zacks
Neutral
Europe markets rally on hopes of an end to U.S. government shutdown; Diageo up 7%
CNBC
Neutral
Zealand Pharma’s Petrelintide Study: A Potential Game-Changer for Diabetes Management
TipRanks News
Neutral
Forget Trump’s tariffs — here's what is separating pharma’s winners and losers
CNBC
Neutral
European markets head for mixed open as U.S. government shutdown holds spotlight
CNBC
Neutral
European health care stocks rise after Trump slaps 100% tariffs on medicine imports
CNBC
Neutral
Roche targets becoming top 3 obesity player as experimental drug enters late-stage trial
CNBC
Neutral

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is ZLDPF’s Media Buzz Sentiment?
Currently, no data Available
What is ZLDPF’s weekly average amount of articles?
Currently, no data Available
What is ZLDPF’s News Sentiment?
Currently, no data Available
Healthcare Stocks that are Trending in the News
ELANElanco Animal Health
KYTXKyverna Therapeutics, Inc.
DBVTDBV Technologies SA - American
CGCCanopy Growth
TLRYTilray
Showing the stocks with the most bullish news sentiment over the past week